Literature DB >> 6241789

Cisplatinum: a review, with special reference to cellular and molecular interactions.

C L Litterst.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6241789     DOI： 10.1007/bf01966766

Source DB:  PubMed          Journal:  Agents Actions        ISSN： 0065-4299


× No keyword cloud information.
  19 in total

1.  Alterations in the toxicity of cis-dichlorodiammineplatinum-II and in tissue localization of platinum as a function of NaCl concentration in the vehicle of administration.

Authors:  C L Litterst
Journal:  Toxicol Appl Pharmacol       Date:  1981-10       Impact factor: 4.219

2.  Increased tissue deposition and decreased excretion of platinum following administration of cisplatin to cisplatin-pretreated animals.

Authors:  C L Litterst; V G Schweitzer
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

3.  Distribution of cis-platin in blood.

Authors:  R C Manaka; W Wolf
Journal:  Chem Biol Interact       Date:  1978-09       Impact factor: 5.192

4.  Cisplatin metabolites: a method for their separation and for measurement of their renal clearance in vivo.

Authors:  P T Daley-Yates; D C McBrien
Journal:  Biochem Pharmacol       Date:  1983-01-01       Impact factor: 5.858

5.  The effects of platinum complexes on seven enzymes.

Authors:  J L Aull; R L Allen; A R Bapat; H H Daron; M E Friedman; J F Wilson
Journal:  Biochim Biophys Acta       Date:  1979-12-07

6.  Ototoxicity of the anticancer drug cisplatin. An experimental study.

Authors:  Y Nakai; K Konishi; K C Chang; K Ohashi; N Morisaki; Y Minowa; A Morimoto
Journal:  Acta Otolaryngol       Date:  1982       Impact factor: 1.494

7.  cis-Dichlorodiammineplatinum nephrotoxicity: time course and dose response of renal functional impairment.

Authors:  R S Goldstein; B Noordewier; J T Bond; J B Hook; G H Mayor
Journal:  Toxicol Appl Pharmacol       Date:  1981-09-15       Impact factor: 4.219

8.  Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion.

Authors:  J J Gullo; C L Litterst; P J Maguire; B I Sikic; D F Hoth; P V Woolley
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

9.  Effect of a forced diuresis on the distribution and excretion (via urine and bile) of 195mplatinum when given as 195mplatinum cis-dichlorodiammineplatinum(II).

Authors:  P A DeSimone; R S Yancey; J J Coupal; J D Butts; J D Hoeschel
Journal:  Cancer Treat Rep       Date:  1979-06

10.  Alterations in hepatic and renal levels of glutathione and activities of glutathione S-transferase from rats treated with cis-dichlorodiammineplatinum-II.

Authors:  C L Litterst; S Tong; Y Hirokata; Z H Siddik
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333
View more
  6 in total

1.  Metallothionein-like proteins and cell resistance to cis-dichlorodiammineplatinum(II) in L1210 cells.

Authors:  P Farnworth; B Hillcoat; I Roos
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  The effect of sodium thiosulfate on ototoxicity and pharmacokinetics after cisplatin treatment in guinea pigs.

Authors:  T Saito; Z J Zhang; Y Manabe; T Ohtsubo; H Saito
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

3.  Quantitative subcellular distribution of platinum in rat tissues following i.v. bolus and i.v. infusion of cisplatin.

Authors:  R Parti; W Wolf
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Dinuclear platinum complexes with N, N'-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands. Part II. Cellular processing in A2780 cisplatin-resistant human ovarian carcinoma cells: new insights into the mechanism of resistance.

Authors:  Ganna V Kalayda; Bart A J Jansen; Chris Molenaar; Peter Wielaard; Hans J Tanke; Jan Reedijk
Journal:  J Biol Inorg Chem       Date:  2004-04-08       Impact factor: 3.358

5.  Dinuclear platinum complexes with N, N'-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands. Part I. Synthesis, cytotoxicity, and cellular studies in A2780 human ovarian carcinoma cells.

Authors:  Bart A J Jansen; Peter Wielaard; Ganna V Kalayda; Maura Ferrari; Chris Molenaar; Hans J Tanke; Jaap Brouwer; Jan Reedijk
Journal:  J Biol Inorg Chem       Date:  2004-04-08       Impact factor: 3.358

6.  Platinum complex-induced dysfunction of cultured renal proximal tubule cells. A comparative study of carboplatin and transplatin with cisplatin.

Authors:  F Courjault; D Leroy; L Coquery; H Toutain
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.